Skip to main content
CARE
NASDAQ Finance

Carter Bankshares Repositions $139M Securities Portfolio, Expects $12.5M Q2 Loss for $4.2M Annual Income Gain

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
8
Price
$27.3
Mkt Cap
$606.661M
52W Low
$16.14
52W High
$27.86
Market data snapshot near publication time

Summary

Carter Bankshares announced a strategic repositioning of its securities portfolio, incurring a $12.5 million pre-tax loss in Q2 2026 but expecting a $4.2 million annual increase in interest income and funding for loan growth.


Key Events

  • Strategic Portfolio Repositioning

    The company sold $139.4 million (book value) of available-for-sale securities with a 2.28% yield, representing 18.7% of its portfolio. It then purchased $88.5 million of AAA or AA-rated securities with a significantly higher yield of 5.27%.

  • Short-Term Financial Impact

    The repositioning is expected to result in an estimated pre-tax loss of $12.5 million on the sale of securities, which will be recognized in the second quarter of 2026.

  • Long-Term Profitability Improvement

    Despite the immediate loss, the company projects an annual improvement in interest income of approximately $4.2 million. The estimated pre-tax loss is expected to be recovered over approximately 2.98 years.

  • Funding for Organic Loan Growth

    The remaining proceeds from the portfolio repositioning are expected to be used to fund organic loan growth, further supporting the bank's core business and future revenue generation.


Analysis

Carter Bankshares has undertaken a significant strategic repositioning of its securities portfolio, selling lower-yielding assets to reinvest in higher-yielding, high-quality securities. While this will result in an estimated $12.5 million pre-tax loss in the second quarter of 2026, the company anticipates recovering this loss within approximately three years. More importantly, the move is expected to boost annual interest income by $4.2 million and provide capital for organic loan growth, signaling a proactive approach to improving net interest margin and long-term profitability.

At the time of this filing, CARE was trading at $27.30 on NASDAQ in the Finance sector, with a market capitalization of approximately $606.7M. The 52-week trading range was $16.14 to $27.86. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CARE - Latest Insights

CARE
May 29, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
CARE
May 07, 2026, 1:33 PM EDT
Filing Type: 10-Q
Importance Score:
9
CARE
May 01, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
CARE
May 01, 2026, 9:33 AM EDT
Source: Wiseek News
Importance Score:
8
CARE
May 01, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Apr 23, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
8
CARE
Apr 23, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 26, 2026, 2:15 PM EDT
Filing Type: 8-K
Importance Score:
9
CARE
Mar 05, 2026, 12:53 PM EST
Filing Type: 10-K
Importance Score:
8
CARE
Feb 02, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8